SCHEMBL30106041

SCHEMBL30106041

Cc1ccc(S(N)(=O)=O)c([C@H]2COC[C@@H]2Oc2nc3c(ccn3COCC[Si](C)(C)C)cc2Br)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29748502 0.94 — —
SCHEMBL25355858 0.80 LMNA (0.33) —
SCHEMBL23166620 0.79 ADAM17 (0.32) —
SCHEMBL23166621 0.79 ADAM17 (0.32) —
SCHEMBL23166619 0.79 ADAM17 (0.32) —
SCHEMBL30106038 0.79 ADAM17 (0.32) —
SCHEMBL29747132 0.76 ADAM17 (0.34) —
SCHEMBL29747201 0.76 ADAM17 (0.34) —
SCHEMBL29747235 0.76 ADAM17 (0.34) —
SCHEMBL29747206 0.75 SLC12A2 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4110298-A1 HOT MELT EXTRUDED SOLID DISPERSIONS CONTAINING A BCL2 INHIBITOR Guangzhou Lupeng Pharmaceutical Company Ltd. (CN) 2023-01-04 — — EP disclosed
Send feedback